Clinical Trials Logo

Clinical Trial Summary

A pilot randomized feasibility trial with a blinded evaluator.


Clinical Trial Description

Chemotherapy-induced peripheral neuropathy (CIPN) has a dose limiting effect which can greatly affect quality of life and often limits the amount of treatment patients can receive in treating their cancer. In the discipline of hand therapy, there is a science-based body of knowledge with effective protocols to treat neuropathies associated with injury and disease. These interventions have not been explored on patients with CIPN. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05374876
Study type Interventional
Source HonorHealth Research Institute
Contact
Status Completed
Phase N/A
Start date May 13, 2016
Completion date September 30, 2021

See also
  Status Clinical Trial Phase
Terminated NCT01359007 - FOLFIRINOX in Patients With Inoperable Pancreatic Cancer Phase 2